Anti-Human CD23/FCER2 Monoclonal Antibody (1A503)
The Anti-Human CD23/FCER2 Monoclonal Antibody (1A503) is a highly specific and potent antibody designed to target the CD23/FCER2 protein in human cells. This protein is a key regulator of the immune response and is primarily found on the surface of B cells and macrophages.
Biological Function
The CD23/FCER2 protein plays a crucial role in the activation and regulation of B cells, which are responsible for producing antibodies to fight off infections. It also helps in the recognition and elimination of foreign substances in the body. This makes it an essential protein in maintaining a healthy immune system.
Main Applications
This monoclonal antibody has been extensively used in research and diagnostic applications due to its high specificity and sensitivity. It has been shown to be effective in identifying and isolating CD23/FCER2-expressing cells, as well as detecting changes in their expression levels. Additionally, it has been used in studies investigating the role of CD23/FCER2 in various diseases, such as allergies, autoimmune disorders, and cancer.
Experimental Use Cases
The Anti-Human CD23/FCER2 Monoclonal Antibody (1A503) has been successfully used in a variety of experimental settings. In one study, it was used to identify and isolate CD23/FCER2-expressing B cells in patients with allergic asthma, providing valuable insights into the role of this protein in the disease. In another study, it was used to detect changes in CD23/FCER2 expression in patients with chronic lymphocytic leukemia, aiding in the diagnosis and treatment of this condition.
This antibody has been extensively tested and validated for its specificity and sensitivity, making it a reliable tool for researchers studying the CD23/FCER2 protein. Its high affinity for the target protein ensures accurate and reproducible results, making it a top choice for scientists in the biotech industry.
In conclusion, the Anti-Human CD23/FCER2 Monoclonal Antibody (1A503) is a highly specific and potent tool for studying the CD23/FCER2 protein in human cells. Its proven effectiveness in various applications and experimental use cases makes it a valuable asset for biotech research. Order now and experience the power of this cutting-edge antibody in your studies.
There are no reviews yet.